Transplantation is the renal replacement therapy of choice for patients with end stage renal disease (ESRD). However, not all patients are suitable candidates for transplantation, and suitability is often determined by the risks of receiving graft versus the risks of not receiving a graft.
Articles in Press, Corrected Proof Available Online from 01 December 2023
Hussein, S. (2023). mTOR Inhibitors versus CNI in Kidney Transplant. Upper Egypt Critical Care Journal, (), 17-20. doi: 10.21608/ueccj.2023.329406
MLA
Safaa Hussein. "mTOR Inhibitors versus CNI in Kidney Transplant". Upper Egypt Critical Care Journal, , , 2023, 17-20. doi: 10.21608/ueccj.2023.329406
HARVARD
Hussein, S. (2023). 'mTOR Inhibitors versus CNI in Kidney Transplant', Upper Egypt Critical Care Journal, (), pp. 17-20. doi: 10.21608/ueccj.2023.329406
VANCOUVER
Hussein, S. mTOR Inhibitors versus CNI in Kidney Transplant. Upper Egypt Critical Care Journal, 2023; (): 17-20. doi: 10.21608/ueccj.2023.329406
)
View on SCiNiTO